PolarityTE Receives Notice of Allowance for Chinese Patent
July 12 2021 - 8:00AM
Business Wire
PolarityTE’s Worldwide Patent Portfolio Grows
to 12 Allowed or Granted Patents
PolarityTE, Inc. (Nasdaq: PTE) today announced that the
China National Intellectual Property Administration (CNIPA) issued
a Notification of Allowance for Chinese Patent Application No.
201580075326.3. The allowed claims relate to skin-regenerative
compositions utilizing PolarityTE’s minimally polarized functional
unit (MPFU) technology as well as methods of making a
skin-regenerative composition utilizing the MPFU technology. Of
note, China recently adopted a new law for patent term extension of
up to 5 years to compensate for the time taken for review and
approval of a new drug or biologic for marketing, where the total
patent term from the approval date of the new drug or biologic
shall not exceed 14 years.
This most recent allowance further demonstrates the Company’s
steady march forward in acquiring patent rights on a global scale
and brings the Company’s total number of allowed and granted
utility patents worldwide to 12 – 10 abroad and 2 in the United
States. The Company continues to pursue additional patent
applications in the United States and abroad related to its
regenerative technologies, including SkinTE®.
David Seaburg, Chief Executive Officer, commented, “In less than
two years, PolarityTE has grown its worldwide patent portfolio from
zero allowed or granted patents to 12.” Mr. Seaburg continued,
“This most recent achievement further bolsters our intellectual
property rights in our MPFU technology, aspects of which are
central to SkinTE®.”
About PolarityTE®
PolarityTE is focused on transforming the lives of patients by
discovering, designing, and developing a range of regenerative
tissue products and biomaterials for the fields of medicine,
biomedical engineering and material sciences. Rather than
manufacturing with synthetic and foreign materials within
artificially engineered environments, PolarityTE manufactures
products from the patient's own tissue and uses the patient's own
body to support the regenerative process. From a small piece of
healthy autologous tissue, the company creates an easily
deployable, dynamic, and self-propagating product designed to
regenerate the target tissues. PolarityTE's innovative methods are
intended to promote and accelerate growth of the patient's tissues
to undergo a form of effective regenerative healing. Learn more at
www.PolarityTE.com – Welcome to the Shift®.
Forward Looking Statements
Certain statements contained in this release are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. They are generally
identified by words such as "believes," "may," "expects,"
"anticipates," "intend," "plan," "will," "would," "should" and
similar expressions. Readers should not place undue reliance on
such forward-looking statements, which are based upon the Company's
beliefs and assumptions as of the date of this release. The
Company's actual results could differ materially due to the impact
of the COVID-19 pandemic, future clinical studies, and FDA
regulatory matters, which cannot be predicted, and the risk factors
and other items described in more detail in the "Risk Factors"
section of the Company's Annual Reports and other filings with the
SEC (copies of which may be obtained at www.sec.gov). Subsequent
events and developments may cause these forward-looking statements
to change. The Company specifically disclaims any obligation or
intention to update or revise these forward-looking statements as a
result of changed events or circumstances that occur after the date
of this release, except as required by applicable law.
POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES
SELF and WELCOME TO THE SHIFT are registered trademarks of
PolarityTE, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210712005140/en/
Investors: Rich Haerle VP, Investor Relations PolarityTE,
Inc. ir@PolarityTE.com (385) 315-0697
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From Mar 2024 to Apr 2024
PolarityTE (NASDAQ:PTE)
Historical Stock Chart
From Apr 2023 to Apr 2024